Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015)
Jazz Pharmaceuticals' quarterly Minority Interest came in at $14000.0 in Q3 2015, down 84.44% year-on-year from $90000.0 in Q3 2014, and down 74.55% quarter-over-quarter from $55000.0 in Q2 2015.
Jazz Pharmaceuticals has reported Minority Interest for 2 years, with the latest figure at $14000.0 in Q3 2015.
- For the quarter ending Q3 2015, Minority Interest fell 84.44% year-over-year to $14000.0; the trailing twelve-month figure through Sep 2015 stood at $14000.0 (down 84.44% YoY), and the FY2014 full-year result was $64000.0, changed N/A from the prior year.
- Minority Interest for Q3 2015 stood at $14000.0, down from $55000.0 in the prior quarter.
- The five-year high for Minority Interest was $17.6 million in Q1 2014, with the low at $14000.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 14,000.00 |
| Jun 30, 2015 | 55,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 396,000.00 |
| Mar 31, 2014 | 17.62 Mn |